Novartis Partnering

CADD 3D Vizualization

Reimagining Medicine through Partnerships

Our partnership approach reflects our commitment to society to help accelerate the discovery and development of transformative medicines for patients worldwide.

Join Novartis for #HealthcarePartneringWeek

Jan 11, 2021 – Jan 15, 2021

Our approach to Partnering


We want to combine and complement our skills with yours to foster your innovation

We have a century-long record in successfully developing medicines and our pipeline is amongst the richest in the Pharma industry. We want to share this R&D experience and combine it with your knowledge and innovation. Further driving our mission to improve and extend people's lives we are prepared to share our expertise with you - even if a successful deal is not accomplished.


We are committed to trusting and mutually successful collaborative partnerships

Completing a deal is only the first step - we want to collaborate with you in the development of your innovation and bringing it to its fruition. We will support your development needs before and after the deal through a dedicated Alliance Management group, who will manage our relationship throughout its lifespan.


We are by nature curious and keen to learn

We welcome innovation - no matter where it originates. Our bold investments in transformational science is a reflection of this. We aspire to learn, adapt and communicate openly about our processes. We have an engaged leadership, who are open to take ‘smart risks’ where new ideas can produce better outcomes for patients, physicians, customers and healthcare systems.

We want to become the Partner Of Choice for your innovation.

Nigel Sheail, Global Head M&A and BD&L

Our Leadership Team

Sourcing innovation, strategically

Phil Gotwals, the Head of BD&L at NIBR, talks about his vision for the future of business development for research.

Read the Story

Partnerships in Focus

Key Therapeutic Areas and focus

  • Image generated using machine learning

    Disease Areas

    Cardiovascular, Renal and Metabolism, Hepatology, Immunology & Dermatology, and Renal, Neuroscience, Respiratory, Ophthalmology & ENT, Musculoskeletal Diseases, Renal / Nephrology

  • Group of business people in a meeting

    Platforms and Technologies

    Cell & Gene Therapy, Digital, Precision Medicine – Diagnostic Technologies, Biologics, Chemistry & Chemical Biology

  • Image of a simplified brain


    Small Molecules & Generics, Biopharmaceuticals

  • A Novartis scientist adjusting equipment in a drug research lab

    Other Divisions & Functions

    M&A, Venture Investments, Alliance Management, Out-licensing and Divestments

Do you have an idea for a transformative innovation and would like to collaborate with us?

Submit Proposal